Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Aarti Pharmalabs Ltd

Pharmaceuticals & Biotechnology | Small Cap

Aarti Pharmalabs Ltd Health Insights
Health Score : 7.46Health Score : 7.46

Aarti Pharmalabs Ltd demonstrates a mixed financial performance. The company shows excellent solvency, growth, coverage, and profitability, indicating a strong ability to meet long-term obligations, expand its operations, cover its financial obligations, and generate profits. Its financial ratios are also strong, driven by high adjusted and cash earnings per share and book value. However, the company's liquidity and efficiency ratios suggest some challenges in managing short-term obligations and utilizing assets effectively. While revenue and profit growth are robust, the company needs to focus on improving its working capital management and asset turnover to achieve a more balanced financial profile. Capital expenditure is a concern. Overall, Aarti Pharmalabs exhibits solid financial health with potential for further improvement in specific areas.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Aarti Pharmalabs Ltd Health Insights
Health Score : 7.46Health Score : 7.46

Aarti Pharmalabs Ltd demonstrates a mixed financial performance. The company shows excellent solvency, growth, coverage, and profitability, indicating a strong ability to meet long-term obligations, expand its operations, cover its financial obligations, and generate profits. Its financial ratios are also strong, driven by high adjusted and cash earnings per share and book value. However, the company's liquidity and efficiency ratios suggest some challenges in managing short-term obligations and utilizing assets effectively. While revenue and profit growth are robust, the company needs to focus on improving its working capital management and asset turnover to achieve a more balanced financial profile. Capital expenditure is a concern. Overall, Aarti Pharmalabs exhibits solid financial health with potential for further improvement in specific areas.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

33.87

Neutral

Industry Median

28.93

Neutral
Overvalued

Small Cap Median

26.92

Overvalued

P/E RATIO

34.17

P/B RATIO

2.81

Neutral

Industry Median

3.18

Neutral
Neutral

Small Cap Median

2.63

Neutral

P/S RATIO

3.13

Neutral

Industry Median

3.41

Neutral
Overvalued

Small Cap Median

2.40

Overvalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

15.47

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹658.5 as on Jun 18, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company exhibits excellent growth across various metrics, including revenue, operating profit, EPS, assets, and net income. This indicates a strong upward trajectory and effective growth strategies. The company's consistent growth positions it well for future success and market leadership.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate62.08-4.7314.14-14
Operating Profit Growth Rate65.2212.8720.21-20.47
Earnings Per Share (EPS) Growth12.0825.57-35.87
Asset Growth Rate1015.0612.5519.82
Net Income Growth Rate58.212.4425.35-35.66
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 7.60

The company demonstrates strong financial performance, driven by high adjusted and cash earnings per share and book value. However, the relatively lower score for dividend per share and capital expenditures indicates areas for potential improvement. The company's financial health is supported by its robust earnings and asset value.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
AverageDividend Per Share (DPS)Average
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)244021.4424.1130.2219.67
Cash Earnings Per Share (Cash EPS)328028.4432.2239.8931
Book Value Per Share27725173.11195.22221.11236
Dividend Per Share (DPS)1.923.115.113.47
Capital Expenditures (CapEx)141120199444448
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company demonstrates excellent profitability, with high gross profit margins, ROCE, ROE, ROA, operating margins, and net margins. This indicates efficient operations and strong financial performance. The company is generating substantial profits from its sales and investments.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin13.7514.3416.8917.8314.57
Return on Capital Employed (ROCE)1916171711
Return on Equity (ROE)8.812.3912.3513.678.24
Return on Assets (ROA)10.1515.2414.9515.9710.6
Operating Margin17.2517.5820.8321.9420.29
Net Margin10.179.9211.7112.869.62
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.33

The company's efficiency in utilizing its assets is generally low. The turnover ratios for fixed assets, inventory, and receivables are not very high, indicating that the company may not be generating sufficient revenue from its asset base. The company needs to improve its asset management practices to enhance overall efficiency as the days sales in inventory and receivable days are high which is not a good sign.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio1.532.11.791.861.19
Inventory Turnover Ratio4.363.092.472.822.53
Receivables Turnover Ratio6.374.73.823.873.14
Days Sales in Inventory Ratio83.72118.12147.77129.43144.27
Receivable Days57.377.6695.5594.32116.24
Capital Turnover Ratio0.861.251.0410.76
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The company exhibits excellent coverage ratios, indicating a strong ability to meet its interest and dividend obligations. The high-interest coverage ratio suggests the company can comfortably handle its interest expenses, while the equity dividend coverage ratio indicates a sufficient capacity to cover dividend payments. The company's strong coverage ratios reduce financial risk and enhance its attractiveness to investors.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio13.9213.4318.6514.375.96
Equity Dividend Coverage Ratio11.117.695.885.56
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits excellent solvency, indicating a solid financial structure and a strong ability to meet its long-term obligations. The low presence of debt in relation to equity and assets suggests a conservative approach to financial leverage, which reduces financial risk. The company's financial stability and long-term sustainability are enhanced by its strong equity position.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio000.010.060.11
Debt to Equity Ratio000.010.060.12
Equity Ratio110.990.940.89
Debt To Asset Ratio000.010.040.07
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 4.76

The company's ability to meet its short-term obligations appears mixed. While the current and quick ratios indicate an acceptable level of liquid assets, the low cash ratio suggests limited immediate liquidity. This could pose challenges in handling unexpected expenses or taking advantage of immediate investment opportunities. However, a positive operating cash flow ratio indicates the company's ability to generate cash from its operations, which can help offset some liquidity concerns.

AverageCurrent RatioAverage
AverageQuick RatioAverage
PoorCash RatioPoor
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.61.651.621.661.32
Quick Ratio0.870.770.820.920.74
Cash Ratio0.130.020.030.010.01
Operating Cash Flow Ratio-0.070.370.270.420.24
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 23 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1FDC Ltd7.6422.22Neutral346.0017.56281.00
2Supriya Lifescience Ltd7.4635.88Highly Overvalued294.0025.98209.00
3Aarti Pharmalabs Ltd7.4634.17Neutral369.0019.44175.00
4Innova Captab Ltd7.3637.88Overvalued243.0014.63141.00
5Akums Drugs & Pharmaceuticals Ltd7.2837.12Overvalued522.007.09256.00
6Marksans Pharma Ltd7.2428.36Neutral601.006.64420.00
7Hikal Ltd7.13-50.15Neutral220.00-3.95-49.00
8RPG Life Sciences Ltd7.1232.71Neutral147.0069.64115.00
9Alembic Ltd7.067.59Undervalued90.004.85317.00
10SMS Pharmaceuticals Ltd5.9434.36Neutral171.009.35102.00
11Shilpa Medicare Ltd5.9443.86Highly Overvalued435.006.80243.00
12Strides Pharma Science Ltd5.5518.41Undervalued925.0019.92575.00
13Jeena Sikho Lifecare Ltd5.5230.78Neutral349.0017.87222.00
14Gufic BioSciences Ltd5.4955.88Neutral151.006.3064.00
15Dishman Carbogen Amcis Ltd5.3827.35Neutral566.00-2.4597.00
16IOL Chemicals & Pharmaceuticals Ltd5.3127.36Undervalued269.004.69138.00
17Aarti Drugs Ltd5.0717.33Undervalued309.0018.54195.00
18Orchid Pharma Ltd4.85248.95Neutral41.008.9121.00
19Sequent Scientific Ltd4.61291.78Overvalued162.000.6332.00
20Sun Pharma Advanced Research Company Ltd4.355.07Neutral1599.0047.831553.00
21Zota Health Care Ltd3.97-59.69Neutral19.008.06-74.00
22Procter & Gamble Health Ltd3.4532.04Neutral457.00196.94327.00
23Sanofi India Ltd3.4518.76Neutral491.00134.52413.00
Management Assessment Summary
OrangeBalanced Management

Aarti Pharmalabs Ltd's management effectiveness presents a balanced view. The company exhibits strong profit growth and improving operating margins, indicating efficient operations. However, increasing borrowings and declining promoter holding raise concerns. While sales growth remains positive, the reduced promoter holding needs attention. Overall, the company's financial performance is solid, but prudent financial management and ownership stability are crucial.

Category Metric Value Assessment
PROS Profit Growth 31% (3Y Compounded) Strong profit growth
OPM 22% (Mar 2025) Improving operational efficiency
CONS Promoter Holding 44.29% (Mar 2025) Declining confidence & alignment
Borrowings ₹413 Cr. (Mar 2025) Increased leverage
GoodFinancial Performance & GrowthGood
AverageCapital Efficiency & ReturnsAverage
AverageFinancial Health & PrudenceAverage
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Aarti Pharmalabs indicates a moderate level of concern due to increasing regulatory compliance costs. Given these factors, the overall risk is assessed as moderate, suggesting that while the company exhibits some strengths, it is exposed to risks that warrant monitoring.

AverageOff-balance sheet exposure quantificationAverage
AverageContingent liability evaluationAverage
AverageRegulatory compliance cost trendsAverage
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Regulatory compliance cost trends

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10674.73Bullish
  3. SMA 20663.06Bullish
  4. SMA 50646.95Bullish
  5. EMA 10676.79Bullish
  6. EMA 20666.75Bullish
  7. EMA 50653.09Bullish
  8. DEMA 10688.29Bearish
  9. DEMA 20681.64Bullish
  10. DEMA 50663.71Bullish
  11. TEMA 10690.67Bearish
  12. TEMA 20687.70Bearish
  13. TEMA 50678.36Bullish
  14. MACD11.77Bullish
  15. ADX47.52Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI67.70Neutral
  3. CCI106.27Overbought
  4. ROC 94.23Bullish
  5. ROC 145.66Bullish
  6. ROC 256.52Bullish
  7. Stoch K65.59Neutral
  8. Stoch D72.26Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper695.43Neutral
  3. BB Middle663.06Neutral
  4. BB Lower630.68Neutral
  5. ATR8.68Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI83.23Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10664.00Bullish
  3. SMA 20653.82Bullish
  4. SMA 50638.18Bullish
  5. EMA 10668.42Bullish
  6. EMA 20657.42Bullish
  7. EMA 50650.88Bullish
  8. DEMA 10682.39Bullish
  9. DEMA 20671.91Bullish
  10. DEMA 50645.09Bullish
  11. TEMA 10687.60Bearish
  12. TEMA 20681.66Bullish
  13. TEMA 50658.86Bullish
  14. MACD11.82Bullish
  15. ADX34.59Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI67.93Neutral
  3. CCI185.45Overbought
  4. ROC 95.62Bullish
  5. ROC 146.52Bullish
  6. ROC 259.14Bullish
  7. Stoch K78.88Neutral
  8. Stoch D87.96Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper686.28Neutral
  3. BB Middle653.82Neutral
  4. BB Lower621.35Neutral
  5. ATR11.01Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI85.20Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10655.62Bullish
  3. SMA 20640.82Bullish
  4. SMA 50662.74Bullish
  5. EMA 10659.40Bullish
  6. EMA 20651.97Bullish
  7. EMA 50661.66Bullish
  8. DEMA 10673.31Bullish
  9. DEMA 20654.59Bullish
  10. DEMA 50644.16Bullish
  11. TEMA 10681.71Bullish
  12. TEMA 20670.12Bullish
  13. TEMA 50N/AN/A
  14. MACD4.30Bullish
  15. ADX22.92Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI65.49Neutral
  3. CCI196.87Overbought
  4. ROC 95.39Bullish
  5. ROC 148.83Bullish
  6. ROC 2510.42Bullish
  7. Stoch K84.25Overbought
  8. Stoch D88.16Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper680.61Overbought
  3. BB Middle640.82Neutral
  4. BB Lower601.02Neutral
  5. ATR15.85Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI79.93Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10633.24Bullish
  3. SMA 20650.38Bullish
  4. SMA 50688.95Bearish
  5. SMA 100696.63Bearish
  6. SMA 200746.82Bearish
  7. EMA 10642.99Bullish
  8. EMA 20652.90Bullish
  9. EMA 50674.88Bearish
  10. EMA 100696.64Bearish
  11. EMA 200723.01Bearish
  12. DEMA 10639.61Bullish
  13. DEMA 20631.43Bullish
  14. DEMA 50650.56Bullish
  15. DEMA 100657.34Bullish
  16. DEMA 200699.03Bearish
  17. TEMA 10650.73Bullish
  18. TEMA 20627.21Bullish
  19. TEMA 50643.17Bullish
  20. TEMA 100648.15Bullish
  21. TEMA 200646.39Bullish
  22. MACD-14.92Bullish
  23. ADX19.55Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI49.53Neutral
  3. CCI6.93Neutral
  4. ROC 143.99Bullish
  5. ROC 25-6.81Bearish
  6. Stoch K69.63Neutral
  7. Stoch D49.68Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper716.60Neutral
  3. BB Middle650.38Neutral
  4. BB Lower584.17Neutral
  5. ATR23.48Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI48.68Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20690.46Bearish
  3. SMA 50768.88Bearish
  4. EMA 20695.46Bearish
  5. EMA 50725.41Bearish
  6. DEMA 20660.47Bearish
  7. DEMA 50719.56Bearish
  8. TEMA 20655.12Bearish
  9. TEMA 50660.00Bearish
  10. MACD-25.67Bearish
  11. ADX15.46Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI43.14Neutral
  3. CCI-123.53Oversold
  4. ROC 14-8.43Bearish
  5. ROC 25-14.18Bearish
  6. Stoch K21.50Neutral
  7. Stoch D32.53Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper782.51Neutral
  3. BB Middle690.45Neutral
  4. BB Lower598.40Neutral
  5. ATR59.98Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI38.17Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6699.13Bearish
  3. SMA 12768.16Bearish
  4. SMA 24726.57Bearish
  5. EMA 6695.55Bearish
  6. EMA 12719.06Bearish
  7. EMA 24681.26Bearish
  8. DEMA 6656.60Bearish
  9. DEMA 12713.84Bearish
  10. DEMA 24N/AN/A
  11. TEMA 6641.15Bearish
  12. TEMA 12657.04Bearish
  13. TEMA 24N/AN/A
  14. MACDN/AN/A
  15. ADX26.17Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI56.33Neutral
  3. CCIN/AN/A
  4. ROC 2523.42Bullish
  5. ROC 50N/AN/A
  6. Stoch KN/AN/A
  7. Stoch DN/AN/A
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper941.49Neutral
  3. BB Middle743.45Neutral
  4. BB Lower545.40Neutral
  5. ATR134.65High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI50.46Neutral